LORETA analysis of three-dimensional distribution of delta band activity in schizophrenia: Relation to negative symptoms

Neuroscience Research

Volumn 70, Issue 4, 2011, Pages 442-448

  Itoh, Toru ^a   Sumiyoshi, Tomiki ^a,b   Higuchi, Yuko ^a   Suzuki, Michio ^a,b   Kawasaki, Yasuhiro ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Delta band activity; Electroencephalography; LORETA; Negative symptoms; Prefrontal cortex; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA BAND ACTIVITY; DELTA RHYTHM; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL GYRUS; HUMAN; INFERIOR FRONTAL GYRUS; INFERIOR TEMPORAL GYRUS; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MALE; MIDDLE TEMPORAL GYRUS; NEGATIVE SYNDROME; NORMAL HUMAN; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; SCHIZOPHRENIA; SUPERIOR FRONTAL GYRUS; THETA RHYTHM; VOXEL BASED MORPHOMETRY;

ADOLESCENT; ADULT; CONTINGENT NEGATIVE VARIATION; DELTA RHYTHM; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; SCHIZOPHRENIA; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79960023246     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.05.003     Document Type: Article

References (52)

1. American Psychiatric Assocatation, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). APA. Washington D.C.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1983, University of Iowa, Iowa City.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1983, University of Iowa, Iowa City.
4. Andreasen N.C., Rezai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., Cohen G., O'Leary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch. Gen. Psychiatr. 1992, 49:943-958.
5. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997, 349:1730-1734.
6. Arai M., Tanaka H., Pascual-Marqui R.D., Hirata K. Reduced brain electric activities of frontal lobe in cortical cerebellar atrophy. Clin. Neurophysiol. 2003, 114:740-747.
7. Begre S., Federspiel A., Kiefer C., Schroth G., Dierks T., Strik W.K. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport 2003, 14:739-742.
8. Buchsbaum M.S., Nuechterlein K.H., Haier R.J., Wu J., Sicotte N., Hazlett E., Asarnow R., Potkin S., Guich S. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br. J. Psychiatr. 1990, 156:216-227.
9. Cleghorn J.M., Garnett E.S., Nahmias C., Firnau G., Brown G.M., Kaplan R., Szechtman H., Szechtman B. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatr. Res. 1989, 28:119-133.
10. Coutin-Churchman P., Moreno R. Intracranial current density (LORETA) differences in QEEG frequency bands between depressed and non-depressed alcoholic patients. Clin. Neurophysiol. 2008, 119:948-958.
11. Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. Br. Med. J. 1980, 280:66-68.
12. Dang-Vu T.T., Schabus M., Desseilles M., Albouy G., Boly M., Darsaud A., Gais S., Rauchs G., Sterpenich V., Vandewalle G., Carrier J., Moonen G., Balteau E., Degueldre C., Luxen A., Phillips C., Maquet P. Spontaneous neural activity during human slow wave sleep. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15160-15165.
13. Flor-Henry P., Lind J.C., Koles Z.J. A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated males with depression. Psychiatr. Res. 2004, 130:191-207.
14. Frith C.D. Functional brain imaging and the neuropathology of schizophrenia. Schizophr. Bull. 1997, 23:525-527.
15. Gross A., Joutsiniemi S.L., Rimon R., Appelberg B. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry 2004, 37:119-122.
16. Guich S.M., Buchsbaum M.S., Burgwald L., Wu J., Haier R., Asarnow R., Nuechterlein K., Potkin S. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Schizophr. Res. 1989, 2:439-448.
17. Harmony T., Fernández T., Silva J., Bernal J., Díaz-Comas L., Reyes A., Marosi E., Rodríguez M., Rodríguez M. EEG delta activity: an indicator of attention to internal processing during performance of mental tasks. Int. J. Psychophysiol. 1996, 24(1-2):161-171.
18. Hazlett E.A., Buchsbaum M.S., Jeu L.A., Nenadic I., Fleischman M.B., Shihabuddin L., Haznedar M.M., Harvey P.D. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr. Res. 2000, 43:33-46.
19. Holmes A.P., Blair R.C., Watson J.D., Ford I. Nonparametric analysis of statistic images from functional mapping experiments. J. Cereb. Blood Flow Metab. 1996, 16:7-22.
20. Ingvar D.H., Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr. Scand. 1974, 50:425-462.
21. Ingvar D.H., Sjolund B., Ardo A. Correlation between dominant EEG frequency, cerebral oxygen uptake and blood flow. Electroencephalogr. Clin. Neurophysiol. 1976, 41:268-276.
22. Kahn E.M., Weiner R.D., Coppola R., Kudler H.S., Schultz K. Spectral and topographic analysis of EEG in schizophrenic patients. Biol. Psychiatr. 1993, 33:284-290.
23. Koles Z.J., Lind J.C., Flor-Henry P. A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated men with schizophrenia. Psychiatry Res. 2004, 130:171-190.
24. Kubicki S., Herrmann W.M., Fichte K., Freund G. Reflections on the topics: EEG frequency bands and regulation of vigilance. Pharmakopsychiatr. Neuropsychopharmakol. 1979, 12:237-245.
25. Kuroki N., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Ersner-Hershfield H., Yurgelun-Todd D., Kikinis R., Jolesz F.A., McCarley R.W. Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am. J. Psychiatr. 2006, 163:2103-2110.
26. Lynch M.R. Schizophrenia and the D1 receptor: focus on negative symptoms. Prog. Neuropsychopharmacol. Biol. Psychiatr. 1992, 16:797-832.
27. Meisenzahl E.M., Koutsouleris N., Bottlender R., Scheuerecker J., Jager M., Teipel S.J., Holzinger S., Frodl T., Preuss U., Schmitt G., Burgermeister B., Reiser M., Born C., Moller H.J. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr. Res. 2008, 104:44-60.
28. Mientus S., Gallinat J., Wuebben Y., Pascual-Marqui R.D., Mulert C., Frick K., Dorn H., Herrmann W.M., Winterer G. Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by low resolution electromagnetic tomography (LORETA). Psychiatr. Res. 2002, 116:95-111.
29. Molina Rodriguez V., Montz Andree R., Perez Castejon M.J., Gutierrez Labrador R., Ferre Navarrete F., Carreas Delgado J.L., Rubia Vila F.J. Cerebral perfusion correlates of negative symptomatology and Parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study. Schizophr. Res. 1997, 25:11-20.
30. Mulert C., Jager L., Schmitt R., Bussfeld P., Pogarell O., Moller H.J., Juckel G., Hegerl U. Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage 2004, 22:83-94.
31. Nakagawa M., Takeda K., Kakimoto Y. Characteristic distribution of alpha 2 wave in electroencephalograms of schizophrenic patients during discriminative tasks: support for the hypofrontality hypothesis of schizophrenia. Acta Psychiatr. Scand. 1991, 83:105-114.
32. Onitsuka T., Shenton M.E., Salisbury D.F., Dickey C.C., Kasai K., Toner S.K., Frumin M., Kikinis R., Jolesz F.A., McCarley R.W. Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study. Am. J. Psychiatr. 2004, 161:1603-1611.
33. Parellada E., Catafau A.M., Bernardo M., Lomena F., Gonzalez-Monclus E., Setoain J. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: a resting and activation SPECT study. Psychiatr. Res. 1994, 55:131-139.
34. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int. J. Psychophysiol. 1994, 18:49-65.
35. Pascual-Marqui, R.D., 1995. Continuing discussion of the inverse problem. ISBET Newsletter (ISSN 0947-5133), pp. 9-30.
36. Pascual-Marqui R.D., Lehmann D., Koenig T., Kochi K., Merlo M.C., Hell D., Koukkou M. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatr. Res. 1999, 90:169-179.
37. Pascual-Marqui R.D., Esslen M., Kochi K., Lehmann D. Functional imaging with low-resolution brain electromagnetic tomography (LORETA): a review. Method Find. Exp. Clin. Pharmacol. 2002, 24(Suppl. C):91-95.
38. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., Schaefer S.M., Koger J.V., Benca R.M., Davidson R.J. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am. J. Psychiatr. 2001, 158:405-415.
39. Potkin S.G., Alva G., Fleming K., Anand R., Keator D., Carreon D., Doo M., Jin Y., Wu J.C., Fallon J.H. A PET study of the pathophysiology of negative symptoms in schizophrenia Positron emission tomography. Am. J. Psychiatr. 2002, 159:227-237.
40. Ragland J.D., Yoon J., Minzenberg M.J., Carter C.S. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Int. Rev. Psychiatr. 2007, 19:417-427.
41. Sabri O., Erkwoh R., Schreckenberger M., Owega A., Sass H., Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997, 349:1735-1739.
42. Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Kurachi M., Sumiyoshi C., Kawasaki Y. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA. Psychiatr. Res. Neuroimaging. 2009, 172:180-183.
43. Sumiyoshi, T., Higuchi, Y., Itoh, T., Kawasaki, Y., 2011. Electrophysiological imaging evaluation of schizophrenia and treatment response. Handbook of Schizophrenia Spectrum Disorders, vol. 3, Nova Science Publishers, New York.(in press).
44. Sumiyoshi T., Matsui M., Yamashita I., Nohara S., Uehara T., Kurachi M., Meltzer H.Y. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia. J. Clin. Psychopharmacol. 2000, 20:386-388.
45. Sumiyoshi T., Sumiyoshi C., Nohara S., Hagino H., Hasegawa S., Kuwayama N., Endo S., Kurachi M. Verbal memory deficits in a preadolescent case of lesions of the left parahippocampal gyrus associated with a benign tumor. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2006, 30:733-736.
46. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System 1988, G. Thieme, Stuttgart.
47. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatr. 1992, 49:522-530.
48. Tislerova B., Brunovsky M., Horacek J., Novak T., Kopecek M., Mohr P., Krajca V. LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia. Neuropsychobiology 2008, 58:1-10.
49. Veiga H., Deslandes A., Cagy M., Fiszman A., Piedade R.A., Ribeiro P. Neurocortical electrical activity tomography in chronic schizophrenics. Arq. Neuropsiquiatr. 2003, 61:712-717.
50. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatr. 1987, 44:660-669.
51. Weinberger D.R., Berman K.F. Prefrontal function in schizophrenia: confounds and controversies. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1996, 351:1495-1503.
52. Wienbruch C., Moratti S., Elbert T., Vogel U., Fehr T., Kissler J., Schiller A., Rockstroh B. Source distribution of neuromagnetic slow wave activity in schizophrenic and depressive patients. Clin. Neurophysiol. 2003, 114:2052-2060.